MOOG Inc.

11/20/2026 | Press release | Distributed by Public on 11/20/2026 11:55

Annual Report for Fiscal Year Ending 10/03, 2026 (Form 10-K)

Management's Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and the related notes appearing elsewhere in this report.
This discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to those under the heading "Risk Factors" in Item 1A of this report.
OVERVIEW
We are a worldwide designer, manufacturer and systems integrator of high performance precision motion and fluid control and control systems for a broad range of applications. We primarily operate in the aerospace and defense market, and also operate in the industrial and medical markets.
Within the aerospace and defense market, our products and systems include:
•Defense market - primary and secondary flight controls and components for military aircraft, tactical and strategic missile steering controls, defense ground vehicle systems including turreted weapon systems and various other defense product components.
•Commercial aircraft market - primary and secondary flight controls and components for commercial aircraft.
•Space market - satellite avionics, propulsion and positioning controls and components, launcher thrust vector controls and components, as well as integrated space vehicles.
Outside of the aerospace and defense market, our products and systems in the industrial and medical markets span a wide range of applications including:
•Industrial market - various components and systems used in applications including: heavy industrial machinery used for metal forming and pressing, flight simulation motion control systems, energy exploration and generation products, material and automotive structural and fatigue testing systems, as well as liquid cooling pumps used in data centers.
•Medical market - pumps and sets for enteral clinical nutrition and infusion therapy, slip rings used in CT scan medical equipment and various components used in ultrasonic sensors and surgical handpieces.
We operate under four segments, Space and Defense, Military Aircraft, Commercial Aircraft and Industrial. Our principal manufacturing facilities are located in the United States, Philippines, United Kingdom, Germany, Italy, Costa Rica, China, Netherlands, Japan, Canada, India and Lithuania.
Under ASC 606, 66% of revenue was recognized over time for the year ended October 3, 2026, using the cost-to-cost method of accounting. The over-time method of revenue recognition is predominantly used in Space and Defense, Military Aircraft and Commercial Aircraft. We use this method for U.S. Government contracts and repair and overhaul arrangements as we are creating or enhancing assets that the customer controls. In addition, many of our large commercial contracts qualify for over-time accounting as our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed to date.
For the year ended October 3, 2026, 34% of revenue was recognized at the point in time control transferred to the customer. This method of revenue recognition is used most frequently in Industrial. We use this method for commercial contracts in which the asset being created has an alternative use. We determine the point in time control transfers to the customer by weighing the five indicators provided by ASC 606. When control has transferred to the customer, profit is generated as cost of sales is recorded and as revenue is recognized.
Our products and technologies make a difference in the lives of millions of people worldwide. Our innovative solutions preserve national security, ensure safe air transportation, improve industrial productivity and enhance patients' lives. Moog engineers collaboratively design and manufacture the most advanced motion control products, to the highest quality standards, for use in demanding applications. By building on these core foundational capabilities, we believe we have achieved a leadership position in the high-performance, precision controls market, and are "Shaping the way our world moves™."
We leverage our engineering expertise and close customer relationships to solve complex technical problems. This approach has enabled us, both organically and through acquisitions, to broaden our capabilities from high-performance components to the design, manufacture and integration of high-performance systems across multiple markets. We continue to expand our content on existing platforms as well, seeking to be the leading precision motion-controls supplier across the markets we serve. We are also modernizing operations through productivity-enhancing technologies and targeted talent development to strengthen operational performance.
Our long-term strategies to achieve our financial objectives focus on pricing and simplification initiatives. Our pricing strategy seeks recognition for the value we deliver to our customers across our markets. Our simplification initiatives, guided by 80/20 principles, include:
•shaping our product and business portfolio to invest in growth areas and divest non-core assets,
•rationalizing our global footprint to meet current and future business volumes,
•focusing our factories to meet the specific needs of each market, and
•investing in automation and technologies to improve operational efficiency.
We aim to improve shareholder value through strategic revenue growth, both organic and acquired, manufacturing and operating efficiencies and utilizing low-cost manufacturing facilities without compromising quality. Historically and over the long-term, our capital deployment strategy has balanced strategic acquisitions, share buybacks and dividend payments to maximize shareholder returns. In the near term, our capital deployment prioritizes investing in our organic growth while opportunistically pursuing acquisitions that complement our business.
Acquisitions, Divestitures and Assets Held for Sale
See Note 3 - Acquisitions, Divestitures and Assets Held for Sale, of Item 8, Financial Statements and Supplementary Data, of this report for details.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Our financial statements and accompanying notes are prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates, assumptions and judgments that affect the amounts reported. These estimates, assumptions and judgments are affected by our application of accounting policies, which are discussed in Note 1 - Summary of Significant Accounting Policies, of Item 8, Financial Statements and Supplementary Data, of this report. We believe the accounting policies discussed below are the most critical in understanding and evaluating our financial results. These critical accounting policies have been reviewed with the Audit Committee of our Board of Directors.
Revenue Recognition on Over-Time Contracts
We recognize revenue from contracts with customers using the five-step model prescribed in ASC 606. For contracts that qualify for over-time treatment, we recognize revenue as control of the promised goods or services is being transferred to the customer. This is accomplished by using the cost-to-cost method of accounting, which measures progress as determined by the ratio of cumulative costs incurred to date to estimated total contract costs at completion, multiplied by the total estimated contract revenue, less cumulative revenue recognized in prior periods. We believe this is an appropriate measure of progress toward satisfaction of performance obligations as this measure most accurately depicts the progress of our work and transfer of control to our customers. Changes in estimates affecting sales, costs and profits are recognized in the period in which the change becomes known using the cumulative catch-up method of accounting. Revenue recognized using the cost-to-cost method of accounting over time for the year ended October 3, 2026 was 66% of total revenue. Revenue and cost estimates for substantially all over-time contract performance obligations are reviewed and updated quarterly. For further information, refer to Note 2 - Revenue from Contracts with Customers and Note 20 - Segments, of Item 8, Financial Statements and Supplementary Data, of this report.
Contract Reserves
At October 3, 2026, we had contract reserves of $83 million. Contract reserves are comprised of contract loss reserves, recall reserves, and contract-related reserves. Contract loss reserves are recorded for open contracts where it is anticipated that contract costs will be greater than contract income and are determined considering all direct and indirect contract costs, exclusive of any selling, general or administrative cost allocations that are treated as period expenses. We calculate contract losses at the contract level, versus the performance obligation level. Recall reserves are recorded when additional work is needed on completed products for them to meet contract specifications. Contract-related reserves are recorded for other reasons, such as delivery issues outside of the ordinary scope of the contract. For all three types of reserves, a provision for the entire amount of the loss is charged against income in the period in which the loss becomes known and can be reasonably estimated by management. For further information, refer to Note 2 - Revenue from Contracts with Customers, of Item 8, Financial Statements and Supplementary Data, of this report.
Reserves for Inventory Valuation
At October 3, 2026, we had net inventories of $938 million, or 35% of current assets. Reserves for inventory were $152 million, or 14% of gross inventories. Inventories are stated at the lower of cost or net realizable value with cost determined primarily on the first-in, first-out method of valuation.
We record valuation reserves to provide for slow-moving or obsolete inventory with the valuation reserve generally increasing as the inventory ages. We also take specific circumstances into consideration. We consider overall inventory levels in relation to firm customer backlog in addition to forecasted demand including aftermarket sales. Changes in these and other factors, such as low demand and technological obsolescence, could cause us to increase our reserves for inventory valuation, which would negatively impact our gross margin. As we record provisions within cost of sales to increase inventory valuation reserves, we establish a new, lower cost basis for the inventory.
Income Taxes
Our annual tax rate is based on our earnings before tax by jurisdiction, applicable statutory tax rates, the impacts of permanent differences, tax incentives and tax planning opportunities in the various jurisdictions in which we operate. Significant judgment is required in determining our annual tax rate and in evaluating our tax positions.
An estimated annual effective tax rate is applied to our quarterly ordinary operating results. For certain significant, unusual or infrequent events, we recognize the tax impact in the quarter in which it occurs.
We record reserves against tax benefits when it is more likely than not that we will not sustain a position if the appropriate taxing jurisdiction had full information and examined our position. We adjust these reserves when facts and circumstances change, such as when progress is made by taxing authorities in their review of our position. There is a considerable amount of judgment in making these assessments. There were no significant reserves taken in 2026.
Valuation allowances associated with deferred tax assets are another area that requires judgment. We record a valuation allowance to reduce deferred tax assets to the amount of future tax benefit that we believe is more likely than not to be realized. We consider recent earnings projections, allowable tax carryforward periods, tax planning strategies and historical earnings performance to determine the amount of the valuation allowance. Changes in these factors could cause us to adjust our valuation allowances, which would impact our income tax expense when we determine that these factors have changed.
At October 3, 2026, we had gross deferred tax assets of $225 million and deferred tax asset valuation allowances of $15 million. The deferred tax assets principally relate to research and development, benefit accruals, inventory obsolescence, tax benefit carryforwards, contract reserves and lease liabilities. The deferred tax assets include $15 million related to tax benefit carryforwards associated with net operating losses and tax credits in certain states, for which $15 million of deferred tax asset valuation allowances are recorded. For further information, refer to Note 14 - Income Taxes, of Item 8, Financial Statements and Supplementary Data, of this report.
CONSOLIDATED RESULTS OF OPERATIONS
The following is a discussion of our results of operations in 2026 compared to 2025 results. A discussion of our 2025 results of operations compared to 2024 results can be found within Part II, Item 7. Management's Discussion and Analysis within our 2025 Annual Report on Form 10-K filed with the SEC on November 26, 2025.
2026 vs. 2025
2025 vs. 2024
(In millions, except per share data)
2026
2025
2024
$ Variance
% Variance
$ Variance
% Variance
Net sales
$
4,523
$
3,861
$
3,609
$
662
17
%
$
252
7
%
Gross margin
28.4
%
27.4
%
28.1
%
Research and development expenses
120
94
113
27
28
%
(19)
(17
%)
Selling, general and administrative expenses as a percentage of sales
13.4
%
14.3
%
13.9
%
Interest expense
66
72
66
(6)
(9
%)
6
9
%
Asset impairment and fair value adjustment
8
5
22
3
(17)
Restructuring expense
6
10
24
(4)
(14)
(Gain) loss on sale of business (6) - -
(6)
-
Other
(2)
10
16
(11)
(7)
Effective tax rate
13.2
%
24.8
%
22.6
%
Net earnings
$
420
$
235
$
209
$
185
79
%
$
26
13
%
Diluted average common shares outstanding 32 32 32 - - % - (1 %)
Diluted earnings per share
$
13.11
$
7.33
$
6.45
$
5.78
79
%
$
0.88
14
%
Total backlog
$
7,730
$
6,010
$
5,060
$
1,720
29
%
$
950
19
%
Twelve-month backlog
$
3,420
$
3,000
$
2,500
$
420
14
%
$
500
20
%
Net sales increased across all our segments in 2026 compared to 2025.
Gross margin increased in 2026 compared to 2025, driven by IEEPA tariff refund claims, as well as by business performance.
Research and development expenses increased in 2026 compared to 2025, driven by activities supporting our current and future growth programs in Space and Defense.
Selling, general and administrative expenses as a percentage of sales decreased in 2026 compared to 2025, reflecting the incremental benefit from higher sales volume.
Interest expense decreased in 2026 compared to 2025, driven by lower outstanding debt balances and lower interest rates.
In 2026 and 2025, we incurred restructuring charges for various simplification activities, primarily within Industrial and Space and Defense.
The effective tax rate was lower in 2026 compared to 2025, driven by our re-evaluation and adjustment of our domestic research and development tax credits. For further information, refer to Note 14 - Income Taxes.
The twelve-month backlog at October 3, 2026 increased as compared with the twelve-month backlog at September 27, 2025. Within Space and Defense, we had higher orders across the entire portfolio of the business, reflecting strong business capture and broad-based growth in both defense and space markets. Commercial Aircraft's twelve-month backlog increased due to the timing of contracts. Industrial's twelve-month backlog increased primarily due to higher demand for data center cooling pumps. Military Aircraft's twelve-month backlog decreased due to the work-down of backlog across various funded development programs.
SEGMENT RESULTS OF OPERATIONS
Segment operating income, as presented below, is net sales less cost of sales and other operating expenses, excluding interest expense, equity-based compensation expense, non-service pension expense and other corporate expenses. Cost of sales and other operating expenses are directly identifiable to the respective segment or allocated on the basis of sales, headcount or profit. Segment operating income is reconciled to earnings before income taxes in Note 20 - Segments, of Item 8, Financial Statements and Supplementary Data, of this report.
Space and Defense
2026 vs. 2025
2025 vs. 2024
(dollars in millions)
2026
2025
2024
$ Variance
% Variance
$ Variance
% Variance
Net sales
$
1,363
$
1,113
$
1,018
$
250
22
%
$
95
9
%
Operating income
$
192
$
131
$
127
$
61
46
%
$
4
3
%
Operating margin
14.1
%
11.8
%
12.5
%
Space and Defense net sales increased in 2026 compared to 2025, reflecting broad-based defense demand including demand for missile controls, ground vehicles and spacecraft components.
Operating margin increased in 2026 compared to 2025, driven by the absence of the prior year's legal settlement charges, and the current year's profitable sales growth and IEEPA tariff refund claims. These increases were partially offset by increased costs for product development, business capture and operational readiness.
Military Aircraft
2026 vs. 2025
2025 vs. 2024
(dollars in millions)
2026
2025
2024
$ Variance
% Variance
$ Variance
% Variance
Net sales
$
1,011
$
888
$
812
$
123
14
%
$
77
9
%
Operating income
$
141
$
99
$
86
$
42
42
%
$
13
16
%
Operating margin
13.9
%
11.1
%
10.5
%
Military Aircraft net sales increased in 2026 compared to 2025. Military OEM sales increased $77 million, driven by higher activity on the MV-75 and F-35 programs. Military aftermarket sales increased $46 million, driven by higher repair activity, new contract awards and a significant V-22 spares order.
Operating margin increased in 2026 compared to 2025, driven by favorable sales mix, pricing, the absence of the prior year's $8 million charge associated with the termination of a product development effort and IEEPA tariff refund claims.
Commercial Aircraft
2026 vs. 2025
2025 vs. 2024
(dollars in millions)
2026
2025
2024
$ Variance
% Variance
$ Variance
% Variance
Net sales
$
1,054
$
904
$
788
$
150
17
%
$
116
15
%
Operating income
$
133
$
112
$
99
$
21
19
%
$
13
13
%
Operating margin
12.6
%
12.4
%
12.5
%
Commercial Aircraft net sales increased in 2026 compared to 2025. Commercial OEM sales increased $100 million, driven by increased volume and pricing on various major production programs. Commercial aftermarket sales increased $50 million, driven by higher repair activity.
Operating margin increased in 2026 compared to 2025, driven by pricing, IEEPA tariff refund claims and the gain on the sale of a business of $6 million. These were partially offset by an unfavorable sales mix, incremental tariff expenses and the benefit of the sale of a non-core product line that occurred in 2025.
Industrial
2026 vs. 2025
2025 vs. 2024
(dollars in millions)
2026
2025
2024
$
Variance
%
Variance
$ Variance
% Variance
Net sales
$
1,095
$
956
$
991
$
139
15
%
$
(36)
(4
%)
Operating income
$
162
$
108
$
93
$
54
50
%
$
15
16
%
Operating margin
14.8
%
11.3
%
9.4
%
Industrial net sales increased in 2026 compared to 2025, driven by strong demand for data center cooling pumps and medical applications, as well as a favorable impact of foreign currency translation.
Operating margin increased in 2026 compared to 2025, driven by the growing data center cooling pump business, IEEPA tariff refund claims, lower charges related to simplification initiatives and an asset impairment recorded in 2025.
LIQUIDITY AND CAPITAL RESOURCES
Consolidated Statement of Cash Flows
2026 vs. 2025
2025 vs. 2024
(dollars in millions)
2026
2025
2024
$
Variance
$ Variance
Net cash provided (used) by:
Operating activities
$
443
$
273
$
198
$
170
$
75
Investing activities
(126)
(175)
(156)
49
(20)
Financing activities
(305)
(98)
(48)
(207)
(50)
Operating activities
Net cash provided by operating activities increased in 2026 compared to 2025. This was primarily driven by higher net earnings and increased customer advances on multiple Commercial Aircraft, Space and Defense and Military Aircraft programs. These were partially offset by accounts receivable, which was driven by the timing of shipments.
Investing activities
Net cash used by investing activities in 2026 included capital expenditures of $136 million, partially offset by net proceeds from the sale of a business of $9 million.
Net cash used by investing activities in 2025 included $145 million of capital expenditures and $41 million associated with the acquisition of COTSWORKS, which were partially offset by $13 million of proceeds from the sales of businesses.
Financing activities
Net cash used by financing activities in 2026 included $114 million of net payments on our revolving credit facilities. In March 2026, we issued $500 million of 5.50% senior notes due 2034 and used the net proceeds of $491 million, together with cash on hand, to redeem all $500 million of our 4.25% senior notes due 2027 in April 2026. We also amended and restated our Credit Facility, extending the maturities of the $1.1 billion revolving loan and the $250 million term loan to February 2031. Financing activities also included $50 million for shares under the authorized repurchase program and $38 million of cash dividends.
Net cash used by financing activities in 2025 included $181 million of net payments on our revolving credit facilities. In addition, on May 30, 2025, we amended and restated our loan agreement to include a $250 million term loan, with a maturity date of October 2027. Financing activities also included $100 million for shares under the authorized repurchase program and $36 million of cash dividends.
General
Cash flows from our operations, together with our various financing arrangements, fund ongoing activities, debt service requirements, organic growth, acquisition opportunities and the ability to return capital to shareholders. We believe these sources of funding will be sufficient to meet our cash requirements for the next 12 months and for the foreseeable future thereafter.
At October 3, 2026, our cash balances were $76 million, the majority of which is held outside of the U.S. by foreign operations. We regularly assess our cash needs, including repatriation of foreign earnings which may be subject to regulatory approvals and withholding taxes, where applicable by law.
Financing Arrangements
In addition to operations, our capital resources include bank credit facilities and an accounts receivable financing program to fund our short and long-term capital requirements. We continuously evaluate various forms of financing to improve our liquidity and position ourselves for future opportunities, which from time to time, may result in selling debt and equity securities to fund acquisitions or take advantage of favorable market conditions.
We are generally not required to obtain the consent of lenders of the U.S. revolving credit facility before raising significant additional debt financing; however, certain limitations and conditions may apply that would require consent to be obtained. We have demonstrated our ability to secure consents to access debt markets. We have also been successful in accessing equity markets from time to time. We believe that we will be able to obtain additional debt or equity financing as needed.
In the normal course of business, we are exposed to interest rate risk from our long-term debt. To manage these risks, we may enter into derivative instruments such as interest rate swaps which are used to adjust the proportion of total debt that is subject to variable and fixed interest rates.
On February 26, 2026, we entered into the Eighth Amended and Restated Loan Agreement (the "Credit Facility"), which amended and restated our prior credit agreement and, among other things, extended the maturity date of our revolving loan from October 27, 2027 to February 26, 2031. The revolving loan has aggregate commitments of $1.1 billion. The agreement also permits us to request incremental revolving commitments and/or one or more incremental term loan facilities in an aggregate amount of up to $400 million, upon satisfaction of certain conditions. The weighted-average interest rate on the outstanding revolving loan borrowings was 5.15% and is based on SOFR plus the applicable margin, which was 1.25% at October 3, 2026. The agreement also includes a $250 million term loan maturing on February 26, 2031. The term loan amortizes in quarterly installments of $5 million in 2027, $6 million in 2028, $11 million in 2029, $9 million in 2030, $6 million in 2031 and the remaining balance on the maturity date of February 26, 2031. The interest rate on the term loan borrowings was 5.27% and is based on SOFR plus the applicable margin, which was 1.25% at October 3, 2026. As of October 3, 2026, we were in compliance with all covenants.
The agreement for the revolving loan and term loan contains various covenants. The minimum for the interest coverage ratio, defined as the ratio of EBITDA to interest expense for the most recent four quarters, is 3.0. The maximum for the leverage ratio, defined as the ratio of net debt to EBITDA for the most recent four quarters, is 4.0. EBITDA is defined in the loan agreement as (i) the sum of net income, interest expense, income taxes, depreciation expense, amortization expense, other non-cash items reducing consolidated net income, non-cash equity-based compensation expenses, unusual or extraordinary non-recurring cash expenses and other synergies related to transactions minus (ii) other non-cash items increasing consolidated net income.
The SECT has a revolving credit facility with a borrowing capacity of $25 million, maturing on April 24, 2028. Interest was 6.01% as of October 3, 2026 and is based on SOFR plus a margin of 2.13%.
On March 24, 2026, we completed the sale of $500 million aggregate principal amount of 5.50% senior notes due October 15, 2034. Interest on the senior notes is payable semiannually on April 15 and October 15 of each year, beginning on October 15, 2026. The senior notes are senior unsecured obligations and are guaranteed on a senior unsecured basis by certain subsidiaries that are guarantors under the indenture. The indenture governing the senior notes contains certain restrictive covenants that, subject to important exceptions and limitations, limit our ability and the ability of certain of our subsidiaries to incur certain liens, enter into certain sale and leaseback transactions and consolidate, merge or sell substantially all of our assets. As of October 3, 2026, we were in compliance with all covenants under the indenture.
On March 4, 2026, we issued a notice of redemption to holders of our 4.25% senior notes due on December 15, 2027, to redeem and retire all of the outstanding notes. The notes were redeemed on April 3, 2026 at a redemption price equal to 100.00% of the principal amount thereof, plus accrued and unpaid interest to, but not including, the redemption date, pursuant to an early redemption right. We redeemed the $500 million aggregate principal amount of the notes using net proceeds available from the issuance of the 5.50% senior notes, together with cash on hand.
At October 3, 2026, we had $1,040 million of unused capacity, including $1,016 million from the U.S. revolving credit facility after considering standby letters of credit and other limitations.
Our Receivables Purchase Agreement, which matures on February 20, 2028, allows the Receivables Subsidiary to sell receivables to the Purchasers in amounts up to a $125 million limit so long as certain conditions are satisfied. The receivables are sold to the Purchasers in consideration for the Purchasers making payments of cash. Each Purchaser's share of capital accrues yield at a variable rate plus an applicable margin, which totaled 4.91% as of October 3, 2026.
We are in compliance with all covenants under each of our financing arrangements. See Note 4 - Receivables and Note 9 - Indebtedness, of Item 8, Financial Statements and Supplementary Data, for additional details regarding our financing arrangements.
Dividends and Common Stock
We believe we can create long-term value for our shareholders by continuing to invest in our business through both capital expenditures as well as investments in new market opportunities. We will also continue exploring opportunities to make strategic acquisitions and return capital to shareholders.
We are currently paying quarterly cash dividends on our Class A and Class B common stock and expect to continue to do so for the foreseeable future. See the Consolidated Statement of Shareholders' Equity and Cash Flows, of Item 8, Financial Statements and Supplementary Data, for additional details regarding our financing arrangements.
The Board of Directors authorized a share repurchase program that permits repurchases for both Class A and Class B common stock, and allows us to buy up to an aggregate 3 million common shares. There are approximately 1.5 million common shares remaining under this authorization. See the Consolidated Statement of Shareholders' Equity and Cash Flows, of Part II, Item 8, Financial Information and Part II, Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities, of this report for additional details.
Off Balance Sheet Arrangements
We do not have any material off balance sheet arrangements that have or are reasonably likely to have a material future effect on our financial condition, results of operations or cash flows.
Contractual Obligations and Commercial Commitments
For further information on our contractual obligations and commitments as of October 3, 2026, see the notes referenced below, of Item 8, Financial Statements and Supplementary Data, of this report.
Right-of-use lease liabilities - See Note 7 - Leases, for details on obligations and timing of expected future payments, including a five-year maturity schedule.
Debt Obligations and Interest Payments - See Note 9 - Indebtedness, for details of our debt and timing of expected future principal and interest payments. Our current and long-term interest obligation on fixed-rate debt is $29 million and $206 million, respectively. Interest on variable-rate long-term debt, assuming the rate and outstanding balances do not change from those at October 3, 2026, would be approximately $19 million annually.
Employee Benefit Plans - See Note 13 - Employee Benefit Plans, for details on our obligations and timing of expected future payments under these plans. In 2027, we anticipate making contributions to defined benefit pension plans of $13 million, of which approximately $6 million is for a non-qualified U.S. plan. We are unable to determine minimum funding requirements beyond 2027. We have made no discretionary incremental contributions to our defined benefit plans in excess of minimum funding requirements. We do not plan to make additional contributions for the foreseeable future.
Income Taxes - See Note 14 - Income Taxes, for additional details regarding unrecognized tax benefits and tax obligations.
Commitments - See Note 21 - Commitments and Contingencies, for additional details.
ECONOMIC CONDITIONS AND MARKET TRENDS
We operate within the aerospace and defense and industrial markets. A common factor throughout our markets is the continuing demand for technologically advanced products.
Our aerospace and defense businesses represented 76% of our 2026 sales. Our defense market, which represented 53% of our 2026 sales, is directly affected by defense funding levels and product demand, which have recently increased. Our commercial aircraft market, which represented 23% of our 2026 sales, is aligning with our customers' current plans. Within our various industrial markets, which represented 24% of our 2026 sales, our customers are affected by a broad range of factors.
Aerospace and Defense
Within aerospace and defense, we serve three end markets: defense, commercial aircraft and space.
The defense market is dependent on military spending for development and production programs. We have a growing development program order book for future generation aircraft and turret programs, and we strive to embed our technologies within these high-performance military programs of the future, including the Textron Bell MV-75. Aircraft production programs are typically long-term in nature, offering predictable capacity needs and future revenues. We maintain positions on numerous high priority programs, including the Lockheed Martin F-35 Lightning II. The large installed base of our products leads to attractive aftermarket sales and service opportunities. The tactical and strategic missile, missile defense and defense vehicle controls markets are dependent on many of the same market conditions as military aircraft, including overall military spending and program funding levels. At times when there are perceived threats to national security, U.S. and European defense spending can increase; at other times, defense spending can decrease. The U.S. Government is currently operating under a continuing resolution through December 11, 2026, pending enactment of annual appropriations for fiscal 2027. An extended continuing resolution or a prolonged government shutdown could delay funding and activity on certain defense programs.
The commercial OEM aircraft market depends on a number of factors, including both the increasing global demand for air travel and increasing fuel prices. Both factors contributed to the demand for new, more fuel-efficient aircraft with lower operating costs that led to large production backlogs for Boeing and Airbus. Boeing and Airbus are producing widebody aircraft at rates to support their projected demand while working through their current supply-chain constraints. Any adjustments to their production rates affect the timing of the demand for our flight control systems.
The commercial aftermarket is driven by usage and the age of the existing aircraft fleet for passenger and cargo aircraft, which drives the need for maintenance and repairs. We have seen higher demand levels for our maintenance services and spare parts due to the increased number of flight hours across existing fleets.
The space market is comprised of three customer markets: civil, U.S. defense and commercial space. The civil market, namely NASA, is driven by investment for exploration activities. The U.S. defense market is driven by government-authorized levels of defense spending, including funding for defense-related satellite and space vehicle technologies. Levels of U.S. defense spending could increase as there is growing emphasis on space as the next frontier of potential future conflicts. The commercial space market is driven by demand for small satellites, which increases the demand for increased launch vehicle capacity. Our launch vehicle and satellite components and systems will continue to benefit from increased investments in each of these markets.
Industrial
Within industrial, we serve two end markets: industrial and medical. The industrial market consists of industrial automation products, simulation and test products and energy generation and exploration products. The medical market consists of medical devices and medical component products.
The industrial market we serve with our industrial automation products is influenced by several factors including capital investment levels, the pace of product and technology innovation, economic conditions and cost-reduction efforts. A portion of our industrial automation customers serve the automotive market as well as the data center cooling market.
Our simulation and test products operate in markets that are largely affected by the same factors as our commercial aircraft market. Demand for our flight simulation systems will match the airline training market and the change in domestic and foreign flight hours.
Our energy generation and exploration products operate in a market that is influenced by changing oil and natural gas prices, global urbanization and the resulting change in supply and demand for global energy. Drivers for global energy growth include investments in power generation infrastructure and exploration of new oil and gas resources.
The medical market we serve, in general, is influenced by economic conditions, regulatory environments, hospital and outpatient clinic spending on equipment, population demographics, medical advances, patient demands and the need for precision control components and systems. Advances in medical technology and treatments have resulted in the greater need for medical services, which drive the demand for our medical devices and medical component offerings.
Foreign Currencies
We are affected by the movement of foreign currencies compared to the U.S. dollar. Approximately one-sixth of our 2026 sales were denominated in foreign currencies. During 2026, average foreign currency rates generally strengthened against the U.S. dollar compared to 2025. The translation of the results of our foreign subsidiaries into U.S. dollars increased sales by $27 million compared to one year ago. During 2025, average foreign currency rates generally strengthened against the U.S. dollar compared to 2024. The translation of the results of our foreign subsidiaries into U.S. dollars increased 2025 sales by $5 million compared to 2024.
RECENT ACCOUNTING PRONOUNCEMENTS
See Note 1 - Summary of Significant Accounting Policies, included in Item 8, Financial Statements and Supplementary Data, of this report for further information regarding Financial Accounting Standards Board issued Accounting Standards Updates ("ASUs").
U.S. GOVERNMENT TARIFFS AND IEEPA TARIFF REFUND CLAIMS
On February 20, 2026, the U.S. Supreme Court held that tariffs imposed under the International Emergency Economic Powers Act ("IEEPA") were invalid. Following the ruling and related proceedings before the U.S. Court of International Trade ("CIT"), U.S. Customs and Border Protection ("CBP") established a process to request refunds of certain tariffs previously paid under IEEPA.
We have paid IEEPA tariffs to the U.S. government and subsequently submitted refund requests to recover those amounts. Based on the court rulings described above, our submission of refund requests and our assessment of the recoverability of amounts paid, we have concluded that recovery of previously incurred IEEPA tariffs is probable under a loss recovery accounting model.
During the year ended October 3, 2026, we recognized $30 million for the recovery of previously incurred IEEPA tariffs. This amount included $28 million of cash refunds received and $2 million recorded in prepaid expenses and other current assets on the Consolidated Balance Sheets as of October 3, 2026. The recovery was recorded as a reduction of cost of sales in the Consolidated Statements of Earnings for the year ended October 3, 2026.
MOOG Inc. published this content on November 20, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 20, 2026 at 17:55 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]